A Study of Uveitis in Children <18 Years of Age
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Uveitis. Basic parameters: up to 17 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The goal of this observational study is to collect data regarding clinical features and current/past treatments in children under 18 with uveitis. The main questions it aims to answer are: * What are the frequency of uveitis subtypes in children? * What are clinical and demographic characteristics overall and within each type of uveitis? Participants will complete one enrollment visit with their doctor. Participants with uveitis onset \<6 months from enrollment date will also partake in a 12 month chart review.
Primary outcome measures
- Frequency of uveitis subtypes in children <18 years of age [Time frame: Enrollment]
Eligibility criteria
Inclusion criteria
- Age:
- Incident cases (onset ≤ 6 months) <17 years
- Established cases (onset > 6 months) <18 years
- Diagnosis of any type of uveitis (infectious or noninfectious) in any location except traumatic and post-operative uveitis.
- Active or inactive uveitis with any treatment status (current / prior / none \[but under surveillance\]).
Exclusion criteria
- Bilateral uveitis with differing etiologies
- Traumatic uveitis
- Post-operative uveitis
- Immediate family member (spouse, biological or legal guardian, child, sibling, parent) who is an investigative site personnel directly affiliated with this study or who is an employee of JAEB Center for Health Research.
- Ocular disease related to Retinoblastoma, Coat's disease, retinitis pigmentosa, inherited retinal degeneration, Juvenile xanthogranuloma (JXG), or leukemia/malignancy within the eye.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
United States · 4 centers
- Department of Ophthalmology, Boston University School of Medicine — Boston
- Akron Children's Hospital — Akron
- Cincinnati Children's Hospital Medical Center — Cincinnati
- Pediatric Ophthalmology Associates, Inc. — Columbus
Identifiers
NCT: NCT07518134 · UV1